Drugs / fluticasone/salmeterol
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00646620 Comparator | Apr → Sep 2003 | asthma | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | fluticasone/salmeterol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00646620 ↗ |